Ruling by
Mariano-Florentino CuéllarLower Court
San Diego County Superior CourtNotwithstanding drugmaker no longer made or sold brand-name drug when it allegedly harmed plaintiff who took drug's generic version, foreseeability and other 'Rowland' factors provide basis for possible failure to warn claim against original drugmaker.
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Civil Litigation, California Supreme Court, Appellate Practice
Product liability decision hits hard, but may not reach far
Jan. 17, 2018
By Don Willenburg
By Don Willenburg
Civil Litigation, Health Care & Hospital Law
Plaintiff’s attorneys appeal overturned $417M talc verdict
Aug. 13, 2019
By Justin Kloczko
By Justin Kloczko
Consumer Law, Civil Litigation, California Courts of Appeal
Appellate ruling frustrates Amazon’s efforts to avoid strict liability for marketplace transactions
Aug. 26, 2020
By Evan Ballan, Benjamin I. Siminou
By Evan Ballan, Benjamin I. Siminou
